Breaking News
February 23, 2018 - Tobacco Kills, No Matter How It’s Smoked: Study
February 23, 2018 - Q&A: Avindra Nath, MD | Medpage Today
February 23, 2018 - Adherence to sleep apnea treatment affects risk of hospital readmission
February 23, 2018 - Zika virus could be alternative for treatment of aggressive brain cancer
February 23, 2018 - Carbon monoxide enhances efficacy of antibiotic against stomach infection
February 23, 2018 - MSD and Ferring Pharmaceuticals Complete Largest Ever Clinical Trial in Postpartum Haemorrhage
February 23, 2018 - Postnova AF2000 system offers reliable characterization of trace metal colloid distribution in the environment
February 23, 2018 - Pioneering study may pave way for effective painkillers to treat neuropathic pain
February 23, 2018 - Research opens up new avenue to minimize risks of transplants
February 22, 2018 - Cabozantinib Active in Advanced Thyroid Cancer
February 22, 2018 - Polluted air may pollute our morality
February 22, 2018 - New data from VOYAGE 2 trial shows promising results for Janssen’s guselkumab treatment
February 22, 2018 - Bank loans signed in the hospital leave patients vulnerable
February 22, 2018 - Researchers identify new nanostructure inside sperm tails
February 22, 2018 - Catheter-based procedure increases treatment options for mitral valve disease
February 22, 2018 - Sage Therapeutics Receives FDA Breakthrough Therapy Designation for SAGE-217 for the Treatment of Major Depressive Disorder
February 22, 2018 - Larger Endocarditis Vegetations More Likely to Embolize, Kill
February 22, 2018 - Parenting behavior in adoptive families
February 22, 2018 - Researchers discover new weakness in sleeping sickness parasites
February 22, 2018 - Research project aims to find new ways to identify and treat most aggressive brain cancers
February 22, 2018 - Researchers explore how people with Alzheimer’s disease use end-of-life medical services
February 22, 2018 - Stroke survivors and carers feel marginalized due to lack of support from primary care
February 22, 2018 - Neuroscientists discover novel mechanism of action behind schizophrenia
February 22, 2018 - After shooting, ‘honor how kids want to deal with their feelings’
February 22, 2018 - U.S., EU and Japan Health Authorities Accept Regulatory Submissions For Review Of Pfizer’s Third-generation ALK Inhibitor Lorlatinib
February 22, 2018 - At-Home Genetic Test Might Change Medicine
February 22, 2018 - Many second hand plastic toys could pose a risk to children’s health, study suggests
February 22, 2018 - Study shows that two different brain systems cooperate during learning
February 22, 2018 - Liquefied brain tissue after stroke may harm surviving brain, UA study finds
February 22, 2018 - New intervention improves communication behaviors in couples affected by dementia
February 22, 2018 - Clinical trial shows safety of promising TSRI stroke drug
February 22, 2018 - Researchers discover new interaction mechanism of unstructured proteins
February 22, 2018 - A Patient’s Journey: Can I Kill the Glucose Monster?
February 22, 2018 - The Problem That Piles Up
February 22, 2018 - Kids can roll up their sleeves—again—for mumps protection
February 22, 2018 - Scientists find significant amounts of toxic metals in e-cigarette vapors
February 22, 2018 - 3D Signatures reports positive results of new Telo-HL test for Hodgkin’s lymphoma
February 22, 2018 - Scientists reveal development of improved medicine to fight addiction
February 22, 2018 - USC-led researchers release dataset of brain scans from stroke patients
February 22, 2018 - Antibiotic-producing bacterium releases more metabolites than assumed
February 22, 2018 - Flu Season Shows First Signs of Slowing
February 22, 2018 - Nonstick Chemicals May Disrupt Metabolic Function in Women
February 22, 2018 - Calcium may play a role in the development of Parkinson’s disease
February 22, 2018 - Scientists visualize insulin receptor activation for the first time
February 22, 2018 - UC San Diego Health now offers new treatment option for people with refractory epilepsy
February 22, 2018 - First African child vaccinated with new typhoid conjugate vaccine
February 22, 2018 - BetterYou named as ‘Most Innovative Brand’ at FGB Awards 2018
February 22, 2018 - Assaults Among Young People Fall to Lowest Rate in 15 Years
February 22, 2018 - What do you know about Parkinson’s disease?
February 22, 2018 - Researchers discover five new genetic changes that may increase pancreatic cancer risk
February 22, 2018 - Gout medication may help improve heart function in adult patients
February 22, 2018 - Bioactive compound limits collateral damage in the kidneys after heart attack
February 22, 2018 - Study reveals HCT as effective treatment for NHL patients regardless of age
February 22, 2018 - Father’s age can affect offspring lifespan, mice study shows
February 22, 2018 - Opiant Pharmaceuticals Announces Publication of New Pre-Clinical Data Supporting Potential of OPNT005 as a Heroin Vaccine
February 22, 2018 - Make the Diagnosis: Strange Rash Surfaces
February 22, 2018 - Isolated sulfite oxidase deficiency – Genetics Home Reference
February 22, 2018 - Scientists identify weight loss ripple effect
February 22, 2018 - Smoking at record lows in New York
February 22, 2018 - Scientists pinpoint fertility hormone that could support early pregnancy
February 22, 2018 - Aggressive cancer stem cells can now be isolated successfully in a scientific breakthrough
February 22, 2018 - Researchers find high risk of suicide among unaccompanied refugee minors
February 22, 2018 - Protein levels linked to posture and gait problems in Parkinson’s
February 22, 2018 - Biomedical engineers create 3D hydrogel scaffolds  to transform cells into muscle
February 22, 2018 - Study employs novel approach to uncover new biomarker for CHD
February 22, 2018 - Study finds strong connection between midwifery and birth outcomes
February 22, 2018 - Verastem Submits NDA to FDA for Duvelisib for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
February 22, 2018 - Low BP Associated With Risk in HFpEF
February 22, 2018 - More U.S. women obese before pregnancy, experts sound the alarm
February 22, 2018 - Study aims to examine effects of PTSD symptoms in police officers
February 22, 2018 - Study reveals increased disease risk after early heart surgery
February 22, 2018 - Women with Type 1 diabetes come across unique challenges
February 22, 2018 - Researchers target abnormal epigenetic mechanisms involved in childhood cancers
February 22, 2018 - Wine polyphenols may be good for oral health
February 22, 2018 - Moderate and severe exacerbations associated with decline in physical activity of COPD patients
February 22, 2018 - FDA Approves Osmolex ER (amantadine) for the treatment of Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions
February 22, 2018 - Morning Break: NSCLC Approval; School Nurses; ‘Human-Sheep Hybrids’?
February 22, 2018 - Penn study sheds new light on immune cell identity
February 22, 2018 - From a novel support group to a book, learning from seven widowed fathers
February 22, 2018 - Researcher makes breakthrough discovery in process of fear relapse
Molecule plays double role in maintaining gut health and promoting diseases

Molecule plays double role in maintaining gut health and promoting diseases

image_pdfDownload PDFimage_print

A molecule that controls intestinal cell growth plays a dual role maintaining gut health and promoting diseases such as cancer, says a study in eLife.

The discovery in mice sheds light on the intricate mechanisms that control cell turnover in the gut, and provides a potential new therapeutic target for intestinal diseases such as bowel cancer.

The lining of our intestine renews rapidly, replacing all of its cells approximately every three days. This rapid turnover is driven by ‘intestinal stem cells’ – precursor cells which originate in tiny crypts deep within the intestinal lining and migrate to the intestine surface where they mature.

Two groups of intestinal stem cells exist – an ‘active’ pool of cells that multiply at a steady rate to replace mature cells, and a ‘dormant’ group of reserve stem cells, which spring into action in response to damage. It is known that the groups are controlled by different mechanisms, but exactly how they each respond to different signals in health and disease remains unclear.

Recently, a group of molecules called microRNAs has been linked to the maintenance of normal intestinal cell turnover. “One microRNA called miR-31 is of particular interest in intestinal stem cells, because its levels increase during the progression of inflammation-associated bowel tumors,” explains lead author Yuhua Tian, a postdoctoral researcher at China Agricultural University in Beijing. This prompted the team to study the function of miR-31 in mouse intestines under normal conditions and after injury.

They found that miR-31 was most present in the intestinal crypts, in cells that were actively growing. After radiation exposure, miR-31 levels sharply increased in regenerative units at 48 hours, suggesting that miR-31 was required for regeneration after injury.

They next studied mice engineered to have higher than normal miR-31 or no miR-31 at all. Mice with higher levels of miR-31 had larger intestinal crypts containing a higher number of stem cells and fewer mature specialised cells. Stem cells also multiplied faster in mice with elevated levels of miR-31. Loss of miR-31 had an adverse effect on regeneration after radiation, with a greater proportion of cells dying in these mice than in normal mice. But switching on miR-31 activated the dormant ‘reserve’ stem cells, allowing them to replenish the depleted pool of growing cells.

Given this role in accelerating growth, the team considered that miR-31 may also be involved in tumor promotion. Indeed, chemicals that mimic miR-31 increased growth of bowel cancer cell lines, and caused larger tumor volume in mice. Of greatest significance, however, was the observation that mice with tumors caused by loss of a gene called Apc developed far fewer tumors when miR-31 was deleted. As loss of Apc is a hallmark of human bowel cancer, miR-31 could be a potential therapeutic target for the disease.

“We have shown that miR-31 is a master regulator of the normal and pathological growth of intestinal stem cells and acts as a promoter of tumor growth,” said senior author Zhengquan Yu, Professor of Biochemistry and Molecular Biology at China Agricultural University. “The next steps will be to build on our insights into the signaling pathways through which miR-31 exerts its effects to fully evaluate its potential as a therapeutic target in cancer.”

Source:

https://elifesciences.org/

Tagged with:

About author

Related Articles